Viz RV/LV vs ClearRead CT
AI Verdict
Choose Viz RV/LV if…
Choose Viz RV/LV if your primary need is rapid, AI-driven risk stratification for suspected pulmonary embolism. This tool excels at automating RV/LV ratio measurements from CTPA scans, facilitating quick clinical decisions and enhancing care team coordination for time-sensitive PE cases.
View Viz RV/LV →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on comprehensive pulmonary nodule detection, characterization, and tracking, alongside coronary artery calcification analysis. Its advanced vessel suppression and nodule management features are ideal for lung cancer screening programs and improving diagnostic accuracy in cardiothoracic imaging workflows.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Viz RV/LV | ClearRead CT |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT focuses on seamless integration into existing PACS workflows, reducing reading times by up to 36% and allowing concurrent reading without additional applications. [cite: JSON, 30] This deep integration directly enhances the radiologist's efficiency within their established environment, minimizing workflow disruption. Viz RV/LV, while offering mobile access and communication, introduces a separate platform for care coordination.
Clinical Value
Viz RV/LVViz RV/LV has demonstrated a significant clinical impact, showing a 74% reduction in in-hospital mortality risk for pulmonary embolism patients when combined with PERT activation. While ClearRead CT offers strong improvements in nodule detection accuracy and reading efficiency, the direct reduction in patient mortality represents a more profound clinical outcome. Both tools are FDA-cleared and supported by clinical studies. [cite: JSON, 2, 5, 11]
Pricing & Value
TieNeither Viz RV/LV nor ClearRead CT provides publicly available pricing information, making a direct comparison of their cost-effectiveness or overall value impossible. [cite: JSON] Both require potential customers to contact the vendor for pricing details, which limits transparency in this dimension.
Enterprise Readiness
ClearRead CTClearRead CT offers superior deployment flexibility with both on-premise and cloud options, catering to diverse IT infrastructure preferences and security policies within large enterprises. [cite: JSON, 15] Its emphasis on vendor-neutral PACS integration and enterprise-wide capability across all CT manufacturers further enhances its readiness for broad adoption in complex healthcare systems.
Innovation
ClearRead CTClearRead CT features patented Vessel Suppression technology, which is a unique and fundamental innovation in image processing that significantly improves nodule conspicuity by removing obscuring vascular structures. [cite: JSON, 10, 15, 25, 27, 30, 35, 36] This distinct technological approach directly addresses a long-standing challenge in radiological interpretation. Viz RV/LV's innovation lies more in automating measurements and care coordination.
Support & Docs
Viz RV/LVViz.ai explicitly highlights a 'dedicated customer success team' comprising clinical and workflow specialists, customer success managers, and clinical research scientists, indicating a comprehensive and proactive support structure. This structured team approach suggests a more tailored and hands-on experience for customers, beyond standard documentation and webinars offered by both.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Viz RV/LV | ClearRead CT |
|---|---|---|
| Primary Function | Automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. | Enhances pulmonary nodule detection and coronary artery calcification analysis in CT scans, improving diagnostic accuracy, reducing reading times, and streamlining radiology workflows through advanced AI and vessel suppression technology. |
| Company | Viz.ai | RIVERAIN TECHNOLOGIES |
| Key AI Focus | Automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement for suspected pulmonary embolism detection. | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression, Nodule Characterization and Measurement, Automated Nodule Tracking, Coronary Artery Calcification (CAC) Scoring. |
| Specialties Supported | Emergency Medicine, Pulmonology, Radiology | Cardiology, Pulmonology, Radiology |
| Categories | Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI | Cardiology AI, Oncology AI, Radiology & Imaging AI |
Videos
Demos, reviews, and walkthroughs featuring Viz RV/LV and ClearRead CT.